INS and Obesity: It should be viewed in the context of the chronic liver disease associated with obesity and diabetes, where intense behavioral treatment [33], also leading to improved glucose control, reduced insulin levels and improved insulin sensitivity [34], is expected to stop liver disease progression [33,35].